High-Sensitivity Troponin T Plasma Levels in Patients With Aortic Stenosis

What this Trial Is About

Researchers are studying the clinical importance of slightly raised high-sensitivity troponin T (hs-TnT) levels in people with both asymptomatic and symptomatic aortic stenosis. This condition can lead to serious heart symptoms like heart failure, fainting, or chest pain, which often guide the decision for valve surgery. The study aims to improve risk assessment beyond current methods, which can be subjective or limited by technical challenges and patient factors like low blood flow or heart valve calcification. The study observes two groups: patients who have had an aortic valve intervention, either surgical or transcatheter, and those with aortic stenosis managed without surgery. Researchers use routine blood tests measuring hs-TnT to evaluate ongoing heart muscle damage or fibrosis. They also consider other clinical evaluations like echocardiography and computed tomography, but focus on hs-TnT as a potentially objective and accessible marker of disease severity. Participants are followed over time to track outcomes including overall and cardiovascular mortality for up to eight years. The study involves regular clinical assessments and blood testing to monitor heart status. By examining these measurements, the research team hopes to better predict disease progression and outcomes for people with aortic stenosis, helping to guide treatment decisions and improve care.

High-Sensitivity Troponin T Plasma Levels in Patients With Aortic Stenosis (Tyrolean Aortic Stenosis Study-2)